Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin

Archives of Internal Medicine
doi 10.1001/archinte.166.8.853
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

Archives of Internal Medicine
2012English

Suboptimal Anticoagulant Management in Japanese Patients With Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention

Journal of Stroke and Cerebrovascular Diseases
SurgeryNeurologyCardiovascular MedicineRehabilitationCardiology
2017English

Patient Satisfaction After Switching From Warfarin to Apixaban in Patients With Nonvalvular Atrial Fibrillation: AGAIN Study

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2017English

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

JAMA Cardiology
Cardiovascular MedicineCardiology
2016English

Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Effect of Ximelagatran and Warfarin on Stroke Subtypes in Atrial Fibrillation

Canadian Journal of Neurological Sciences
MedicineNeurology
2008English

Cost-Effectiveness Analysis of Apixaban Against Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation in Japan

Clinical Therapeutics
Pharmacology
2015English

Platelet Activation in Patients With Chronic Nonvalvular Atrial Fibrillation

International Heart Journal
MedicineCardiovascular MedicineCardiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy